Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome
- PMID: 33451288
- PMCID: PMC7809853
- DOI: 10.1186/s12887-021-02494-6
Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome
Abstract
Background: The last two decades brought new treatment options and high quality guidelines into the paediatric rheumatologic practice. Nevertheless, a number of patients still present a diagnostic and therapeutic challenge due to combination of vague symptoms and unresponsiveness to available treatment modalities.
Case presentation: We report a case of sixteen years old girl suffering from polyarticular type of juvenile idiopathic arthritis refractory to multiple treatment options. She first presented at the age of 4 with swelling and contractures of both knees. Her symptoms were initially unresponsive to nonsteroidal anti-inflammatory drugs and progressed despite treatment with intraarticular and systemic glucocorticoids and methotrexate. Throughout the years, she received several biologics together with continuous administration of nonsteroidal anti-inflammatory drugs and disease modifying anti-rheumatic drugs as well as intraarticular and systemic glucocorticoids in disease flares. However, none of this options provided a permanent remission, so various other modalities, as well as other possible diagnoses were constantly being considered. Eventually she became dependent on a daily dose of systemic glucocorticoids. In 2018, the treatment with Janus kinase inhibitor tofacitinib was initiated, which led to gradual amelioration of musculoskeletal symptoms, improvement of inflammatory markers and overall well-being, as well as to the weaning of systemic glucocorticoids. As the swelling of the wrists subsided for the first time in many years, Madelung's deformity was noticed, first clinically, and later radiographically as well. Genetic analysis revealed short-stature homeobox gene deficiency and confirmed the diagnosis of Leri Weill syndrome.
Conclusions: This case report emphasizes the need for reporting refractory, complicated cases from everyday clinical practice in order to build-up the overall knowledge and share experience which is complementary to available guidelines. Individual reports of difficult to treat cases, especially when additional diagnoses are involved, can be helpful for physicians treating patients with common rheumatological diseases such as juvenile idiopathic arthritis.
Keywords: Case report; Juvenile idiopathic arthritis; Leri Weill syndrome; Madelung deformity; Tofacitinib..
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Glucocorticoids in juvenile idiopathic arthritis.Ann N Y Acad Sci. 2014 May;1318:65-70. doi: 10.1111/nyas.12436. Epub 2014 Apr 16. Ann N Y Acad Sci. 2014. PMID: 24738483
-
Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis.Pediatrics. 2019 May;143(5):e20182845. doi: 10.1542/peds.2018-2845. Epub 2019 Apr 4. Pediatrics. 2019. PMID: 30948682
-
Juvenile Idiopathic Arthritis.Balkan Med J. 2017 Apr 5;34(2):90-101. doi: 10.4274/balkanmedj.2017.0111. Balkan Med J. 2017. PMID: 28418334 Free PMC article.
-
The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.Expert Opin Pharmacother. 2016;17(5):703-14. doi: 10.1517/14656566.2016.1133592. Epub 2016 Jan 13. Expert Opin Pharmacother. 2016. PMID: 26678914 Review.
-
Management of Juvenile Idiopathic Arthritis: A Clinical Guide.Paediatr Drugs. 2016 Dec;18(6):397-412. doi: 10.1007/s40272-016-0186-0. Paediatr Drugs. 2016. PMID: 27484749 Review.
Cited by
-
Monogenic disorders as mimics of juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2022 Jun 18;20(1):44. doi: 10.1186/s12969-022-00700-y. Pediatr Rheumatol Online J. 2022. PMID: 35717242 Free PMC article.
-
Acquired Madelung's deformity as a cause of recurrent monoarthritis in a young patient.Arch Rheumatol. 2024 Aug 26;39(3):467-470. doi: 10.46497/ArchRheumatol.2024.10548. eCollection 2024 Sep. Arch Rheumatol. 2024. PMID: 39507847 Free PMC article. No abstract available.
-
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report.Rheumatol Ther. 2023 Feb;10(1):293-300. doi: 10.1007/s40744-022-00496-z. Epub 2022 Nov 29. Rheumatol Ther. 2023. PMID: 36443570 Free PMC article.
-
JAK Inhibition in Juvenile Idiopathic Arthritis (JIA): Better Understanding of a Promising Therapy for Refractory Cases.J Clin Med. 2023 Jul 14;12(14):4695. doi: 10.3390/jcm12144695. J Clin Med. 2023. PMID: 37510809 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials